MedTrace Logo

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

NCT02351960 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 296

Last updated 2017-10-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effectiveness of symptom control in gastroesophageal reflux disease (GERD) participants following treatment with dexlansoprazole.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DRUG

Dexlansoprazole

Dexlansoprazole capsules

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-19
Primary Completion
2016-06-22
Completion
2016-07-13

Countries

  • Hong Kong
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02351960 on ClinicalTrials.gov